Clinical Trials Logo

Clinical Trial Summary

The primary outcome measure is to compare efficacy of an association of Secnidazol(2g)-Ciprofloxacin(1g) (during 3 days) versus 3g of Amoxicillin-Clavulanic Acid during 10 days for the Treatment of Uncomplicated Episode of Diverticular Sigmoïditis Among Adults in clinical and biological cure.

The cure rate will be evaluated at the second visit (14 days after the inclusion visit)


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01733966
Study type Interventional
Source Quanta Medical
Contact
Status Terminated
Phase Phase 3
Start date May 2010
Completion date March 2012